BioSpace News Archive

Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, announces the use of their HPV-SEQ test in the prospective University of Chicago clinical trial,1 “Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer.”

Zero Gravity Solutions, Inc. (“ZGSI” or the “Company”) (Pink Sheets: ZGSI), an agricultural biotechnology company, announced that the International Journal of Biochemistry Research and Review has published a peer reviewed research paper outlining the mechanism by which the Company’s technology activates plants’ innate disease defenses.

Southern California cord blood therapeutics company StemCyte Inc. is announcing successful preliminary results for Phase I of the company’s clinical trial for treating acute cerebral stroke using monocytes from allogeneic human umbilical cord blood (hUCB).

The Vascular Care Group, a state-of-the art practice committed to the prevention, diagnosis and treatment of vascular disease, announced the hiring of Sebastian DiDato, MD, FACS, RPVI, MPH to its Leominster, Mass.

ACCUMTM is an enabling technology as it can be used to enhance the intracellular accumulation of various proteins of pharmacological interests into any target cells.

Polaris Pharmaceuticals, Inc. Vacaville has purchased 15 acres in the City of Vacaville’s Vaca Valley Business Park, a transaction that represents another advancement in the City’s plans to expand its biotechnology footprint and solidify itself as a global center for biomanufacturing.

Over 150 presenting Medtech startup companies and over 100 investors will come together for the third annual Life Science Intelligence (LSI) USA ’22 Emerging Medtech Summit.

Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal second quarter ended December 31, 2021, on Thursday, February 10, 2022, at 5:00 p.m. ET.

University Lab Partners (ULP), the premier, non-profit, wet lab/medtech incubator located in UCI Research Park, celebrates its 2-year anniversary with 100% capacity.

The translation of research into the development of innovative and life-saving microbial therapies is set to transform in Australia through a partnership between Hudson Institute of Medical Research and BiomeBank, a clinical stage microbiome therapeutics company.